Refine by:
-
Letter to Congressional Committee Leadership on Research & Innovation
Letter to Senate HELP and House Energy & Commerce Committees leadership, expressing support for the Anna Westin Legacy Act of 2022 (S.3686/H.R.7249), which will reauthorize and expand the Substance Abuse and Mental Health Services Administration’s Center of Excellence for Eating Disorders. -
Letter to Congressional Committee Leadership on Research & Treatment Innovation
Letter to Appropriations Committee leadership, requesting $3.75 billion for the Centers for Disease Control and Prevention’s National Center for Chronic Disease Prevention and Health Promotion. -
Letter to Senate Leadership on Research & Treatment Innovation
Letter to Senators Bennet and Cornyn, in response to request for input, urging the inclusion of incentives for adoption of behavioral health information technology in the forthcoming mental health package and supporting the investment in integrated care. -
Letter to Senate Committee Leadership on Gun Violence Research
Letter to Senate Appropriations leadership, requesting $50M in funding shared evenly between the Centers for Disease Control and Prevention and the National Institutes of Health to conduct public health research into firearm morbidity and mortality prevention. -
Letter to Congressional Bill Sponsors on COVID-19 Research and Treatment Innovation
Letter to Representatives Tonko and Katko, expressing support for the reintroduction of H.R. 6645, the “COVID-19 Mental Health Research Act,” which directs HHS to conduct or support research on the mental health consequences of COVID-19. -
Letter to HHS Secretary on Treatment Innovation
Letter to HHS Acting Secretary Cochran, urging the withdrawal of the proposed rule on extramural research involving human fetal tissue. -
Letter to President Biden on Treatment Innovation
Letter to President Biden, urging to rescind the human fetal tissue research restrictions and policy changes that the Department of Health and Human Services made in 2019.
